18 June 2013
Keywords: mgi, pharma, salagen, gained, orphan, drug, status
Article | 06 April 1992
MGI Pharma has gained orphan drug status from the US Food and Drug
Administration for Salagen (pilocarpine), to treat dry ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 April 1992
4 May 1992
© 2013 thepharmaletter.com